GlassScriptPhysician profile
Larry S Kramer
NPI 1134118664
$2,210.37
in general payments reported to CMS, 2019-2025
26 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $717 · 2022: $345 · 2023: $323 · 2024: $426 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $451.35 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $340.43 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $280.16 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $140.27 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $133.87 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Abbott Laboratories | $84.63 | 2022-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.35 | 2024-2025 | Xifaxan |
| Ucb, INC. | $74.17 | 2021-2023 | Cimzia |
| Neurelis, INC. | $69.34 | 2021-2023 | Valtoco |
| Bayer Healthcare Pharmaceuticals INC. | $69.05 | 2024-2025 | |
| Amarin Pharma, INC. | $54.33 | 2021-2022 | |
| Medtronic, INC. | $53.11 | 2021-2023 | Interstim, Vanta Adaptivestim |
| Mylan Specialty L.P. | $42.41 | 2022-2024 | Yupelri |
| Pfizer INC. | $41.73 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $36.66 | 2025 | Voquezna |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.12 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.04 | 2021 | |
| Exact Sciences Corporation | $34.01 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $32.86 | 2021 | |
| Corcept Therapeutics | $20.45 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.00 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $17.77 | 2021 | |
| Sumitomo Pharma America, INC. | $16.67 | 2024 | Gemtesa |
| Philips North America LLC | $14.84 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.